Clinical Trial

Polycystic Ovary Syndrome, Mitochondrial Dysfunction, Obesity, Insulin Resistance Infertility (POMODORI) Cohort

Study acronym: POMODORI
Recruiting
View on ClinicalTrials.gov →
Summary
Enrolling of 150 female patients of fertile age diagnosed with PCOS, insulin resistance, infertility, or mitochondrial disease, and the same number of age- and sex-matched controls are planned. During the research biomarkers already with mitochondrial dysfunction in the scientific literature and common mtDNA abnormalities (deletions, point mutations, copy number changes, etc.) are examined.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-12-03.
Trial Details
NCT Number NCT06167135
Lead Sponsor Semmelweis University
Conditions Infertility, Female, Polycystic Ovary Syndrome, Insulin Resistance, Primary Ovarian Insufficiency, Mitochondrial Alteration, Obesity
Enrollment 150 participants
Start Date 2021-09-10
Primary Completion 2033-09-30 (estimated)
Study Completion 2033-09-30 (estimated)
Updated on ClinicalTrials.gov 2023-12-18